Quantcast

Latest Biologic Stories

2014-11-05 12:26:58

Drug Developers will Rely on Head-to-Head Clinical Trial Data Against Current Therapies to be Poised to Compete in the Increasingly Crowded TNF-alpha-Refractory Space BURLINGTON, Mass., Nov.

2014-11-03 12:27:43

DALLAS, November 3, 2014 /PRNewswire/ -- According to the new market research report The "Single Use Bioreactor Market by Product Type (Recombinant Proteins, Monoclonal

2014-11-03 08:34:08

Funding round for development of leading bone growth regeneration medicine protein EDISON, N.J., Nov.

2014-10-30 08:36:28

BEIJING, Oct. 30, 2014 /PRNewswire/ -- China Biologic Products, Inc.

2014-10-29 16:28:36

Payers Employ a Variety of Cost-Control Measures to Manage the Utilization of Premium-Priced RA Agents, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct.

2014-10-22 20:23:26

Launches discussion about the future of biosimilars in Italy ROME, Oct.

2014-10-20 08:32:21

Expands rHuPH20 Production SAN DIEGO, Oct. 20, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the U.S.


Word of the Day
marcescent
  • Withering but not falling off, as a blossom that persists on a twig after flowering.
The word 'marcescent' comes from a Latin word meaning 'to wither'.
Related